His areas of interest include pharmacological interventions targeted against inflammatory disorders and organ toxicity to find out the various signaling pathways related to oxidative stress, apoptosis and inflammation. He has also been working in the area of Novel Drug Delivery Systems, particularly in the area of ligand coupled nanostructures nanocarriers such as polymeric, solid lipid nanoparticles and dendrimers, for various drug targeting applications particularly to brain.